News
Smallpox vaccine extends life in cancer trial - Reuters
www.reuters.com
A genetically engineered smallpox vaccine reduced the risk of death for patients with advanced liver cancer by nearly 60 percent in a mid-stage study,...
Results of world-first viral therapy trial in cancer patients published ...
www.biologynews.net
JX-594 was developed in partnership with Jennerex Inc., a biotherpeutics company co-founded by Dr. Bell in Ottawa and Dr. David Kirn in San Francisco. JX-594 is derived from a strain of vaccinia virus that has been used ...
GM virus shrinks cancer tumours in humans | New Scientist
www.newscientist.com
A pox virus carefully engineered to thrive in cancer tumours has shown promise for treating liver cancer in human trials
Smallpox vaccine virus puts cancer in its sights | News | Chemistry...
www.chemistryworld.com
Anti-cancer virus can infect tumours but leaves healthy tissue unharmed
sorted by relevance / date